BRIEF-Arena Pharma completes trial of once-daily, extended release Ralinepag formulation

* Arena Pharmaceuticals completes trial comparing once-daily, extended release formulation of Ralinepag with twice-daily, immediate release formulation in normal healthy volunteers Source text for Eikon: Further company coverage: